127
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Synthesis and antiproliferative evaluation of novel 1,3,4-thiadiazole-S-alkyl derivatives based on quinazolinone

ORCID Icon, , , , &
Pages 591-601 | Received 10 Nov 2022, Accepted 30 Jan 2023, Published online: 16 Feb 2023
 

Abstract

Thirty-five novel 1,3,4-thiadiazole-S-alkyl derivatives based on quinazolinone have been designed and synthesized. The structures of the target compounds 5a  5p and 6a  6s were confirmed by their IR, 1H NMR, 13C NMR, HR-ESI-MS spectroscopic data. This study detected their cytotoxicity for mouse fibroblast (normal cells, L929) and their in vitro antiproliferative activities against human cancer cell lines (Hela, MCF-7 and A549) by using CCK-8 assay. The results of all the tested compounds 5a  5p and 6a  6s showed that the growth and reproduction of cells were impeded to a certain extent. Compared with the reference drug 5-FU, some compounds even showed better proliferation inhibition against various cancer cells. Among these, most of the compounds had relatively less cytotoxicity to L929 cells. 6-Chloro-2-(2-(benzylthio)-1,3,4-thiadiazol-5-yl)-quinazolin-4(3H)-one (6a) gave expression to the strongest inhibitory activity on Hela cells with IC50 value of 1.40 µM. 6-Chloro-2-[2-(4-trifluoromethylbenzylthio)-1,3,4-thiadiazol-5-yl]-quinazolin-4(3H)-one (6s) displayed high antitumor activities against MCF-7 cells with IC50 values of 3.01 µM. 2-[2-(Benzylthio)-1,3,4-thiadiazol-5-yl]-quinazolin-4(3H)-one (5a) revealed excellent antitumor activities against A549 cells with IC50 values of 2.21 µM.

Graphical Abstract

Disclosure statement

The authors declare no conflict of interest.

Additional information

Funding

We are grateful to the Tianjin Municipal Natural Science Foundation (18JCYBJC94900).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.